I
n vivo coronary arterial tone is regulated by local metabolic demand and neurohormones, 1 mean and phasic pressures (ie, myogenic response), 2 and endothelium-mediated shear stress. [3] [4] [5] [6] NO is well established as a prominent modulator of the latter. 7, 8 However, growing evidence supports an additional pathway resistant to NO synthase (NOS) and cyclooxygenase (COX) inhibition, involving a hyperpolarizing factor (EDHF). 9, 10 Although the precise nature of EDHF remains somewhat controversial, [11] [12] [13] a common footprint is its activation of calcium-dependent potassium (K ϩ Ca ) channels inhibitable by charybdotoxin (CbTX) plus apamin (AP). 14, 15 These channels may also be activated by NO and cGMP, 16, 17 suggesting some role of K ϩ Ca channel conductance to NO 18 and shear-stress signaling as well.
The presence of an EDHF pathway is based largely on in vitro studies in which vascular hyperpolarization is directly observed with increased shear 19 or pulsatile stretch. 20 Existing in vivo data are scant and have reported only on agonist stimulation. 21 Furthermore, translating in vitro findings to the intact heart is nontrivial, because the latter shows unaltered basal coronary tone despite K ϩ Ca ϩNOS-COX blockade, 21, 22 whereas in vitro, this combination constricts. Because intact vessels are continually exposed to mechanical stimuli, K ϩ Ca activation may play a greater role when vascular stresses are enhanced, as from higher pulsatility with exertion. Increased pulsatility alone elevates in vivo coronary flow, 23, 24 despite unaltered regional function and metabolism, an effect blunted by half by NOS inhibition yet amplified by concomitant low-dose adenosine. 23, 24 The role for K ϩ Ca activation in this response is unknown but is suggested by previous in vitro data 20 and studies showing exercise training enhancement of endothelium-mediated vasorelaxation by NO and hyperpolarization-dependent signaling. 25 The present study tested the hypothesis that K ϩ Ca channels contribute prominently to coronary flow modulation by increased perfusion pulsatility, separate from that due to NOS stimulation. We further probed channel subspecificity for this pulsatile signaling by comparing it to that for bradykinin (BK) and acetylcholine (ACh). We show a prominent contribution of K ϩ Ca channels to in vivo pulsatile flow modulation and reveal signaling similarities with BK-induced dilation, with a dominant role of intermediate-and small-conductance channels.
Methods
The protocol was approved by the Animal Care and Use Committee of the Johns Hopkins University. Coronary pulse pressure (PP) was varied with a computer-controlled servo-system previously reported. 23, 24 Adult mongrel dogs (Ϸ25 to 30 kg) were anesthetized with pentobarbital (30 mg/kg IV) and fentanyl (50 mg/kg IV) (nϭ25) or ␣-chloralose/urethane (0.1/1.0 g/kg IM) (nϭ3) and ventilated with enhanced inspired oxygen to maintain physiological arterial PO 2 , PCO 2 , and pH. The latter tested specific effects of pentobarbital anesthesia on coronary vascular responses. Responses with either anesthesia were similar, so data were combined for analysis. COX activity was inhibited by indomethacin (5.0 mg/kg IM). After heparinization (8000 IU bolus, 1000 IU/h), arterial blood withdrawn from a femoral artery was pressurized at 100 mm Hg constant pressure and passed through a heat-exchanger/filter and onto a 30-mL chamber with a movable floor coupled to a linear motor. The floor position was regulated by digital real-time feedback generating the desired PP. Exiting blood passed through a rigid cannula inserted into the proximal left anterior descending coronary artery, filled with an in-line ultrasound volume-flowmeter (2N; Transonic). Perfusate pressure was measured by micromanometer (SPC 350, Millar Instruments), providing feedback for the servo-system. Central aortic pressure was digitally recorded, modified in computer memory to generate a waveform with the desired pulse amplitude, and then played back in real time as the command signal to the servo-pump. Heart rate was constant by atrial pacing (100 to 120 bpm). Varying regional PP has been found not to alter regional or global myocardial function 23 or energetics. 24 
Pharmaceuticals
N-Monomethyl-L-arginine (L-NMMA) was from CalBiochem. AP, CbTX, iberiotoxin (IbTX), ACh, BK, and sodium nitroprusside were from Sigma. Adenosine (Adenocard) was from Fujisawa USA. Diethylamine/NO was provided by Dr David A. Wink (Radiation Biology Branch, NIH, Bethesda, MD). Each drug was dissolved in isotonic saline at 37°C just before use and administered intracoronarily through a side port in the servo-perfusion cannula at Յ2 mL/min. Coronary flow was unaltered by saline alone at such rates.
Experimental Protocols
PP was set to 40 mm Hg, and the preparation was allowed to stabilize for 15 to 20 minutes. Data were subsequently obtained with PP set to 40 or 100 mm Hg at the same mean pressure. Steady state was always observed after 30 to 60 seconds. 24 Data were recorded over 60 to 90 seconds, starting 2 minutes after a PP change. PP was varied between the two levels repeatedly to obtain multiple files for each condition, and results were averaged. Basal flow, PP-altered flow, and agonist-altered flow (ACh 150 g/30 s IC and BK 100 g/30 s IC) were assessed under the following conditions: (1) baseline (nϭ28); (2) 5-minute pretreatment and continued infusion of AP (15 nmol/min IC; mean concentration of 417 nmol/L at 36 mL/min average coronary blood flow) and CbTX (1.5 nmol/min IC, 42 nmol/L) to broadly block K ϩ Ca channels (nϭ20); (3) recontrol after CbTXϩAP washout (10 to 15 minutes after both agents were discontinued); (4) L-NMMA (nϭ20) (0.5 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 IC) administered 20 minutes before and continuing during PP and agonist testing; and (5) combined CbTXϩAPϩL-NMMA (nϭ11).
The dose of CbTX was based on in vitro studies 12,20,26 -28 showing the effectiveness of a 10 to 100 nmol/L concentration for inhibiting maximal ACh or BK responses, as well as previous in vivo studies. 21, 29 In preliminary studies, this dose combined with L-NMMA fully prevented maximal BK-induced dilation, supporting the adequacy of the concentration.
In 7 dogs, the protocol was conducted with IbTX (4.7 nmol/min, 131 nmol/L) substituted for CbTX. IbTX is a highly selective high-affinity blocker of large K ϩ Ca channels that does not affect intermediate-or small-conductance K ϩ Ca channels. 28, 30 This dose was 3 times higher than that previously studied in vivo. 21, 29 Last, AP alone was tested (nϭ6) and PP and agonist testing performed. Animals receiving IbTX did not receive CbTX. Not all portions of the protocol were obtained in each animal; hence, different sample sizes are noted for each condition.
Data Analysis and Statistics
Hemodynamic data were digitized at 200 Hz and analyzed offline with custom software. Mean and pulsatile coronary flow and pressure, left ventricular pressure, and aortic flow were measured in each study. Data were analyzed with repeated-measures ANOVA, with a Tukey test for multiple comparisons. All data are presented as meanϮSEM.
Results

K ؉
Ca and NO Modulation of Basal Coronary Tone
Basal flow at 40 mm Hg PP in the left anterior descending coronary artery territory averaged 36.7Ϯ17.7 mL/min (nϭ28). This is close to 1.0 mL ⅐ g Ϫ1 ⅐ min Ϫ1 for these hearts, similar to flows measured before servo-pump regulation. 23, 24 Inhibition of K ϩ Ca by CbTX-AP, IbTX-AP, or AP alone did not significantly alter basal flow (Table) . Mean flow declined slightly but significantly with L-NMMA. Subsequent addition of K ϩ Ca channel blockers did not reduce flow further, although the combination of CbTX-APϩL-NMMA was also lower than the pre-L-NMMA baseline. Figure 1A displays example steady-state tracings of phasic coronary pressure and mean coronary flow at 40 or 100 mm Hg pulsatility. Elevating PP augmented mean flow by ϩ18.3Ϯ2.4% (36.0Ϯ4.5 to 41.8Ϯ4.9 mL/min, nϭ20, PϽ0.0001). CbTXϩAP blunted this response to ϩ11.9Ϯ2.9% (PϽ0.001) ( Figure 1B and 1C) . It was fully restored on rebaseline to ϩ20.6Ϯ3.9% but declined similarly with L-NMMA (ϩ11.7Ϯ2.3%, PϽ0.0001). Importantly, 
K ؉
Ca and NO Modulation of PulsatilityStimulated Flow
Baseline Coronary Flow in Isolated Servo-Perfused Left Anterior Midproximal Descending Artery Under Various Experimental Protocols
Comparison With BK-and ACh-Stimulated Flow
Although K ϩ Ca inhibition did not alter basal coronary tone and NOS inhibition had modest effects, each alone and in combination profoundly altered agonist-stimulated dilation. Figure 2A displays coronary flow at 40 mm Hg PP before and after agonist administration, and Figure 2B summarizes these data. Both ACh and BK achieved near-maximal flow responses (ACh ϩ274.6Ϯ22.7%, BK ϩ274.5Ϯ24.6%). CbTXϩAP blunted BK responses by Ϫ66.3Ϯ5.2% (residual ϩ89Ϯ20% flow rise, nϭ13), whereas the ACh response declined to a lesser extent (Ϫ44.5Ϯ7.2%, Pϭ0.016 versus BK, nϭ11). The opposite was observed with L-NMMA: NOS inhibition reduced ACh more than BK flow elevation (BK Ϫ45.8Ϯ7.0%, ACh Ϫ70.6Ϯ3.1%, PϽ0.01 versus BK). Disparities were also observed when these agents were combined, revealing full inhibition of BK flow responses, similar to PP signaling, but residual ACh-induced flow elevation (ϩ41.3Ϯ8.1%, PϽ0.001).
Subchannel Selectivity of K
؉
Ca Response
To selectively test the role of large-conductance K ϩ Ca channels in PP and agonist-stimulated signaling, we substituted IbTX for CbTX ( Figure 3A) . IbTX-AP blunted PP and BK flow responses to less than half the level observed with CbTX-AP, both with and without concomitant NOS inhibition. Furthermore, IbTX-AP had no appreciable effect on ACh-mediated flow reserve and yielded an inhibition similar to that with L-NMMA alone when combined with the latter.
To test whether the residual inhibitory effect on both PP and BK signaling by IbTX-AP was due to AP itself, further studies were performed that used only AP. The absolute reduction in response to either PP or BK stimulation with AP alone was virtually identical to that with IbTX-AP ( Figure  3B ). This supports AP rather than IbTX as the active agent.
Discussion
This study demonstrates for the first time that in vivo, K 
Comparison to Previous In Vivo Studies
Several studies have explored the role of K ϩ Ca channels in vivo, although to date this has focused only on agonist-or ischemia-dependent signaling. For example, Nishikawa et al 22 reported that residual dilation to ACh in Ͻ100-mdiameter arterioles was inhibited by suffusion with K ϩ buffer or by K ϩ Ca blockade. NOS-COX inhibition alone was effective in blocking ACh dilation in less distal arterioles, supporting a more prominent role of NO signaling in such vessels. 31 Node et al 21 reported that CbTX or IbTX combined with L-NAME prevented or blunted BK and (BK-dependent) postischemic dilation. Ischemic protection by 17␤-estradiol, which appeared largely modulated by NO and BK, was inhibited by IbTXϩL-NAME, 29 suggesting that K ϩ Ca channel activation, like K ϩ ATP -channel activation, 32 plays an important role in modifying the impact of coronary supply/demand imbalance. Pulse-perfusion signaling may be relevant in this regard, helping to explain beneficial effects of exercise (with enhanced PP) on flow reserve. 25 
Pulse Perfusion Signaling Mechanisms
Although pulse frequency (heart rate) has been shown to influence in vivo coronary flow, 33 this alters metabolic demand and chamber load in addition to flow pulsation. Our preparation facilitated the study of PP effects alone, confirming a role of NO release, 23 the lack of accompanying change in regional and global myocardial function or regional myocardial oxygen consumption. 23, 24 Although modest under basal (autoregulating) conditions, PP flow augmentation is amplified by low levels of adenosine or K ϩ ATP channel agonists, 24 suggesting that the mechanism may play a more prominent role when PP normally rises, as during exertion.
Increasing PP in vivo alters both phasic shear and vascular distension, and as with NO, K ϩ Ca channel activation or EDHF signaling appears to be involved with both stimuli in vitro. 3, 20 Static stretch of smooth muscle cells stimulates K ϩ Ca channels, 34 whereas pulsatile stretch of porcine coronary vessels with NOS/COX inhibition releases EDHF 20 13, 37 suggesting incomplete NOS blockade. If true in our study, residual NO would have to preferentially act via K ϩ Ca activation. Although NO and cGMP can activate these channels, 16, 17 this has been documented only for largeconductance channels, requiring substantial NO levels. Such channels played a minor role in contrast to small-and intermediate-conductance channels in our preparation. Furthermore, the diminutions of PP responses by L-NMMA and CbTX-AP were nearly equal (separately and combined), which would not be expected if substantial cross-talk between NO-and K ϩ Ca -dependent signals occurred. Finally, the L-NMMA dose was 4 times that shown to fully prevent in vivo ACh-mediated dilation in conductance arterioles (Ͼ100 m). 22 Last, coronary microvessels and larger arteries undergo sustained dilation in response in increases in PP 38, 39 that might lower coronary resistance to enhance flow. However, both mean pressure and PP were identical for all protocols, despite near-complete inhibition of PP flow responses with CbTX-APϩL-NMMA. This is probably not due to prevention of smooth muscle distensibility, because basal coronary flow was little altered, and vasorelaxation to NO donors was preserved.
Role of Small-and Intermediate-Conductance K ؉
Ca Channels
The pharmacological inhibitor sensitivities of the PPmediated flow changes most closely matched those observed with BK stimulation. Unlike ACh, both PP and BK responses were nearly or fully blocked by combined CbTX-APϩL-NMMA and partially diminished by AP alone. IbTX altered none of these responses. BK induces vasorelaxation in the coronary microcirculation principally by membrane hyperpolarization. 40, 41 Combined NOS inhibition and CbTX-AP consistently inhibits this, whereas diminished blockade is observed with IbTX. 42 CbTX blocks both intermediate- 28, 30 and large-conductance channels, 26 whereas IbTX selectively inhibits the latter. 20 At concentrations greater than those used in the present study, CbTX can also inhibit voltage-gated K ϩ channels; however, these are not thought to play a prominent role in coronary endothelium. 43 AP is relatively selective for small-conductance channels. Thus, our results support a dominant role for intermediate-and small-conductance K ϩ Ca channels to the PP response. The observed selectivity for inhibiting BK, ACh, and PP responses to CbTX-AP but not IbTX-AP is supported by several previous in vitro studies in renal vessels 44 and rat hepatic artery. 45 However, some discrepancies with earlier data have been reported in coronary vessels. For example, IbTX inhibited NOS-COX-independent ACh-induced dilation 22 and BK-induced dilation in canine coronary arteries. 21 The specific nature of the preparation and/or dose of agonist may play a role. For example, the BK-agonist dose used by Node et al 21 was Ϸ5% that in the present study. At this dose, L-NMMA also fully inhibited BK flow increases (33.9 versus 33.0 mL/min, mean ⌬CBF Ϫ0.96Ϯ1.0, PϭNS) in 3 of 4 studies, whereas addition of IbTX blocked the residual response in the fourth study. This suggests a greater involvement of IbTX-insensitive channels at higher BK doses. Importantly, this selectivity is similar to that observed for pulsatile perfusion.
Residual ACh-mediated dilation despite full inhibition of BK (or PP) signaling with CbTX-APϩL-NMMA is a novel observation that suggests an NO-, K 
Study Limitations
Regional myocardial metabolism was not directly measured to test whether K ϩ Ca blockade specifically altered PP metabolic interactions and thus, potentially, flow responses. However, previous data revealed no effect of elevating PP on local myocardial oxygen consumption under basal conditions or with concomitant adenosine, BK, verapamil, 24 or epinephrine (unpublished data), making such interaction unlikely. Only one CbTX (or IbTX) dose was studied, largely because of the expense of these agents even for intracoronary in vivo studies. Although this cannot confirm maximal inhibition, full blockade of high-dose BK dilation by CbTXϩAPϩL-NMMA is compatible with an adequate if not maximal inhibitory effect.
Enhancing in vivo perfusion PP alters both phasic stretch and flow, and one cannot separate the primary stimulus in this setting. It remains possible that different findings would be observed with less compliant vessels (ie, aging), where pulse distension would be lower. Furthermore, the in vivo preparation cannot definitively identify whether vascular smooth muscle or endothelial K ϩ Ca channels are the dominant effectors of the dilatory response. In vitro studies 12, 27 applying intraluminal CbTX have shown a greater role for the endothelial channels; other studies showed that both barium and ouabain were necessary to inhibit the vascular smooth muscle hyperpolarization, whereas CbTXϩAP was sufficient in endothelial cells. 14 
Conclusions
Like NO signaling, K ϩ Ca channel activation plays a minimal role in modulating basal coronary tone, yet a prominent one when stimulated by agonists such as ACh and BK or by pulsatile perfusion. This suggests that along with K ϩ ATP channels, adenosine, and NO, K ϩ Ca channels most likely contribute to vasodilator reserve during exertional stress. This is the first study to reveal a role for these channels in vivo for non-agonist-stimulated flow. Recent studies suggest that EDHF-dependent vascular dilation maybe upregulated when NO signaling is downregulated, such as in congestive heart failure 46 or, conversely, downregulated when inducible NO expression is enhanced, ie, sepsis and atherosclerosis. 47 This and the present data support the importance of determining those signals that activate this pathway in vivo in normal and diseased hearts.
